Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations Meeting Abstract
| Authors: | Janku, F.; Elez, E.; Iyer, G.; Yamamoto, N.; Tan, D. S. W.; Stathis, A.; Stammberger, U. M.; Evans, H.; Seroutou, A.; Mais, A.; Schuler, M. H. |
| Abstract Title: | Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 198s |
| Language: | English |
| ACCESSION: | WOS:000560368302012 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3640 |
| Notes: | Meeting Abstract: 3640 -- Source: Wos |
